Article Details

Pluristem Therapeutics Inc. (PSTI) Receives Average Rating of “Buy” from Analysts

Retrieved on: 2019-03-21 05:22:30

Tags for this article:

Click the tags to see associated articles and topics

Pluristem Therapeutics Inc. (PSTI) Receives Average Rating of “Buy” from Analysts. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC increased its stake in Pluristem Therapeutics by 5.8% in the 3rd quarter. <b>Renaissance Technologies</b> LLC now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up